Pyridine derivatives as cb2 receptor modulators

The present invention relates to novel pyridine derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increase or decrease in activity of the cannabinoid receptor.

Saved in:
Bibliographic Details
Main Authors NAYLOR ALAN, EATHERTON ANDREW J, GREEN RICHARD H, PALOMBI GIOVANNI, DOUGHTY JENNIFER M, WHITTINGTON ANDREW R, GIBLIN GERARD M.P, JANDU KARAMJIT S, MITCHELL WILLIAM L, RAWLINGS DEREK A, SLINGSBY BRIAN P
Format Patent
LanguageEnglish
Published 07.06.2007
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to novel pyridine derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increase or decrease in activity of the cannabinoid receptor.
Bibliography:Application Number: US20030528592